| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |